Roll Call: LA HB403 | 2023 | Regular Session
For additional roll call votes on Louisiana HB403 please see the Vote List
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]
Text: Latest bill text (Chaptered) [PDF]
Vote: Senate Vote on HB 403 FINAL PASSAGE (#540)
Vote | Tally | Democrat | Republican |
---|---|---|---|
Yea | 39 | 12 | 27 |
Nay | - | - | - |
Not Voting | - | - | - |
Absent | - | - | - |
TOTAL | 39 | 12 | 27 |